Characterization of real-world progression from non-proliferative to proliferative diabetic retinopathy in patients with diabetes

This presentation reports the analysis utilizing real-world data to characterize baseline, follow-up, and testing attributes of a real-world population with NPDR and to report progression to PDR. Elucidating how retinal imaging and VA correlate in DR can improve understanding of disease progression/phenotypes, and assist in better DR management at all stages as well as the development of personalized treatment paradigms

{{assetTitle}}

Authors {{assetAuthors}}

Published date{{formattedPublishDate}}

{{assetDescription}}

Welcome to Medically

The Roche Science Hub

This website is a non-promotional global resource intended to facilitate transparent scientific exchange regarding developments in medical research, diagnostics, and disease management. It is intended for healthcare professionals.

Not a healthcare professional? Browse:

This global website is intended for healthcare professionals outside the UK, US, Canada and Australia. The content on this website may include scientific information about experimental or investigational compounds, indications and services that are not approved or valid in your jurisdiction. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website. Information available on this website does not constitute professional medical advice, and Roche and Genentech accept no responsibility for access to or use of the same.

You are Leaving Medically

By following this link, you are leaving Roche Website and entering a site that is not owned or controlled by Roche. Roche does not take any responsibility for acces to or use of this website, nor for any content therein.